Therapeutic targets for amyotrophic lateral sclerosis: current treatments and prospects for more effective therapies

Expert Review of Neurotherapeutics
Lucie I Bruijn, Merit Cudkowicz

Abstract

Although amyotrophic lateral sclerosis (ALS) was described more than 130 years ago, the cause(s) of most cases of this adult motor neuron disease remains a mystery. With the discovery of mutations in one gene (Cu/Zn superoxide dismutase) as a primary cause of some forms of ALS, model systems have been developed that have helped us begin to understand mechanisms involved in motor neuron death and enabled testing of potential new therapies. Several other genes have been implicated as risk factors in motor neuron diseases, including neurofilaments, cytoplasmic dynein and dynactin, vascular endothelial growth factor, and angiogenin. With advances in the basic research of the disease, many hypotheses accounting for motor neuron death are being explored, including loss of trophic support, protein mishandling, mitochondrial dysfunction, excitotoxicity, axonal abnormalities and inflammation. Many of these mechanisms are the focus of research in other neurodegenerative disorders, such as Parkinson's, Alzheimer's and Huntington's disease.

References

Aug 1, 1991·Annals of Neurology·J D RothsteinD B Drachman
Jan 1, 1992·Experimental Neurology·A Alvarez-Buylla
Jul 1, 1990·Annals of Neurology·J D RothsteinJ T Coyle
Feb 1, 1984·Journal of the Neurological Sciences·M B Delisle, S Carpenter
Nov 1, 1981·Journal of Neuropathology and Experimental Neurology·Y KawamuraH Doi
Jul 1, 1995·Annals of Neurology·J D RothsteinR W Kuncl
May 1, 1995·Journal of Neurochemistry·A C BowlingR H Brown
Dec 22, 1994·The New England Journal of Medicine·M E Gurney
Jan 31, 1995·Proceedings of the National Academy of Sciences of the United States of America·M E RippsJ W Gordon
Aug 16, 1994·Proceedings of the National Academy of Sciences of the United States of America·D R BorcheltD W Cleveland
Mar 3, 1994·The New England Journal of Medicine·G BensimonV Meininger
Jan 1, 1996·Annual Review of Neuroscience·M K Lee, D W Cleveland
Oct 1, 1996·Neurology·J D Rothstein
Oct 1, 1996·Neuropathology and Applied Neurobiology·L I Bruijn, D W Cleveland
Feb 1, 1997·Annals of Neurology·M E CudkowiczR H Brown
Jul 22, 1998·Proceedings of the National Academy of Sciences of the United States of America·R T MatthewsM F Beal
Feb 5, 1999·Human Molecular Genetics·A Al-ChalabiP N Leigh
Oct 4, 2000·JAMA : the Journal of the American Medical Association·B A HoslerR H Brown
Nov 30, 2000·Proceedings of the National Academy of Sciences of the United States of America·P PasinelliD W Cleveland
Apr 3, 2001·Nature Medicine·D J AndersonI L Weissman
Jul 24, 2001·Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·P M Andersen
Jul 24, 2001·Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·S KatoE Ohama
Jul 27, 2001·Amyotrophic Lateral Sclerosis and Other Motor Neuron Disorders : Official Publication of the World Federation of Neurology, Research Group on Motor Neuron Diseases·M GaudetteT Siddique
Sep 27, 2001·Proceedings of the National Academy of Sciences of the United States of America·D J Selkoe

❮ Previous
Next ❯

Citations

Jul 4, 2009·Nanomedicine·Ari NowacekHoward E Gendelman
Jan 30, 2014·Proceedings of the National Academy of Sciences of the United States of America·Rhona SeijffersRobert H Brown
Jul 3, 2007·Expert Opinion on Emerging Drugs·Richard S BedlackMerit E Cudkowicz
Jul 27, 2007·Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases·R Lee MosleyHoward E Gendelman
Apr 25, 2015·Angewandte Chemie·Peter SchröderHerbert Waldmann
Jul 1, 2010·Cytotherapy·Josep GamezInmaculada Bori-Fortuny
Apr 28, 2010·Experimental Cell Research·Haruhisa Inoue
Sep 19, 2009·Journal of Bodywork and Movement Therapies·Kendra Blatzheim
Jan 1, 2007·Progress in Polymer Science·A V Kabanov, H E Gendelman
Aug 23, 2006·Nature Reviews. Neuroscience·Piera Pasinelli, Robert H Brown
Jun 20, 2020·Nature Reviews. Neuroscience·Peter McColganGeraint Rees
Jan 10, 2008·Journal of Medicinal Chemistry·Andrea CavalliCarlo Melchiorre

❮ Previous
Next ❯

Related Concepts

Related Feeds

Arterial-Venous in Development & Disease

Arterial-venous development may play a crucial role in cardiovascular diseases. Here is the latest research.

ALS: Pathogenic Mechanisms

Amyotrophic Lateral Sclerosis is a progressive neurodegenerative disorder characterized by muscle weakness. Here is the latest research investigating pathogenic mechanisms that underlie this genetically heterogeneous disorder.

Amyloid Lateral Sclerosis

Amyotrophic Lateral Sclerosis (ALS) is a progressive nervous system disease associated with the death of neurons that control voluntary muscles. Discover the latest research on ALS here.